U.S. Markets closed

S&P Futures
4,464.33
-9.92(-0.22%)
Dow Futures
34,696.80
-52.20(-0.15%)
Nasdaq Futures
15,486.67
-31.08(-0.20%)
Russell 2000 Futures
2,241.04
+7.84(+0.35%)
Crude Oil
71.40
-0.57(-0.79%)
Gold
1,748.50
-2.90(-0.17%)

Philip Morris International Inc. (PM)

NYSE - NYSE Delayed Price. Currency in USD

Add to watchlist

101.86-0.97 (-0.94%)

At close: 4:00PM EDT

Trade prices are not sourced from all markets

Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies

Neutralpattern detected

All

Motley Fool
Got $1,000? Here Are 2 Unstoppable Dividend Stocks to Buy
Johnson & Johnson (NYSE: JNJ) and Philip Morris International (NYSE: PM) are two such reliable dividend payers. At $435 billion (by market capitalization), healthcare titan Johnson & Johnson is a favorite of many dividend investors for several reasons. The pharmaceutical segment is led by immunology drugs such as Stelara and Tremfya, and cancer drugs such as Darzalex and Imbruvica (which is co-owned by Johnson & Johnson and AbbVie).
Barrons.com
Microsoft, Texas Instruments, and Other Companies That Raised Their Dividends This Week
Microsoft plans to boost its quarterly payout by 6 cents, or 11%, to 62 cents a share from 56 cents.
Quartz
Philip Morris wants to sell you inhalers for your asthma
Philip Morris, the maker of Marlboros, has bought an asthma inhaler manufacturer, as part of its effort to turn itself into a pharma company. Healthcare advocates don't like it.